Resultados de la búsqueda 11-20 of 13691 for Small lung nodule

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

2. Hematología - Ensayos clínicos - Mayo Clinic

   Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

4. Hematología - Ensayos clínicos - Mayo Clinic

   Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... mass. Combination Therapy Of Acalabrutinib ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung ...

6. Médicos y departamentos

   What is chronic cough? American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/chronic-cough/learn-about-chronic-cough.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

10. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...